Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy

This publication has 32 references indexed in Scilit:

• A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas
  Cancer, 2006
• Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1998
• Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma
  Cancer Chemotherapy and Pharmacology, 1997
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• EORTC trial non-Hodgkin lymphomas
  European Journal of Cancer and Clinical Oncology, 1987
• National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
  Cancer, 1982
• Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-hodgkin's lymphoma
  International Journal of Radiation Oncology*Biology*Physics, 1980
• CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized study
  Cancer, 1979
• Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas
  Radiology, 1973
• Reticulum-Cell Sarcoma
  Radiology, 1970